Brief: Forward Pharma Appeals The Decision Of The Opposition Division To Revoke The EP2801355 Patent
May 7 (Reuters) - Forward Pharma A/S FWP.O :
* FORWARD PHARMA APPEALS THE DECISION OF THE OPPOSITION
DIVISION
TO REVOKE THE EP2801355 PATENT
* FORWARD PHARMA A/S - COMPANY HAS UNTIL AUGUST 2, 2018 TO
SUBMIT
ITS DETAILED GROUNDS OF APPEAL
Source text for Eikon: ID:nGNX8hDhNy
Further company coverage: FWP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Forward Pharma A/S
See all newsBrief: Forward Pharma- Announces Termination Of Its American Depositary Receipts Facility
U.S. STOCKS ON THE MOVE-Madrigal, Disney, Forward Pharma
Forward Pharma slides to record low on delisting notice from Nasdaq
Brief: Forward Pharma Announces Delisting Its American Depositary Shares From Nasdaq Capital Market
Brief: Forward Pharma A/S Submitted A Request For A Written Decision Regarding Petition For Review Regarding EP2801355 To The EBA